Taipei, Taiwan

1-10 employees

Seed

AHEAD: Ai-assisted HEmatologic Analytic and Decision Support

Taipei, Taiwan

1-10 employees

Seed

We focus on developing diagnostic and clinical decision support solutions for hematologic malignancies using artificial intelligence.

Categories

Artificial Intelligence

Health Care

Data and Analytics

Keywords

Hematology, AI, Diagnostic, MedTech, DigitalHealth

About Us

We are a multi-disciplinary team focusing on developing diagnostic and clinical decision support solutions for hematologic malignancies using artificial intelligence. Our co-founders Andrea, Kevin, and Jeremy provide a perfect synergy of data science, clinical medicine, and artificial intelligence expertise. Currently, we have developed a residual leukemia cell detection model (AHEAD-flow) that reduce the interpretation time from 20 minutes to 7 seconds and a relapse/mortality prediction model (AHEAD-mcap) with over 80% accuracy for acute leukemia.

Quotes

Our vision is to enable AI aided clinical decision making in blood cancer management for every physician at each step of clinical decision and optimize treatment strategy with greater ease.

Andrea

CEO

Founder’s Story

Product Feature

Team

Andrea Wang

Co-founder and CEO

Kevin Ko

Co-founder

Jeremy Lee

Co-founder

John Li

AI engineer

Selly Lu

AI engineer

Ming-Ya Ko

AI engineer

Shawn Tsai

cofounder and COO

Abaw Chen

Director of RD

Willy Sung

Data Scientist

Tim Chang

Medical Data Scientist

Press Contact

Andrea Wang

andrea.wang@aheadmedicine.com

+886919393398